BOCA RATON, Fla., Sept. 05, 2017 — Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, will present at the following upcoming investor conferences in September:
|19th Annual Rodman & Renshaw Global Investment Conference
|Date and Time:
|Monday, September 11, 2017 at 4:15 p.m. Eastern time
|Lotte New York Palace Hotel in New York City
|Sidoti & Company Fall 2017 Conference
|Date and Time:
|Thursday, September 28, 2017 at 11:25 a.m. Eastern time
|New York Marriott Marquis at Times Square
Due to Hurricane Irma’s South Florida expected path, management is cancelling its presentation at the 6th Annual Liolios Gateway Conference on September 6, 2017.
Mr. Sardano’s presentation at the Rodman & Renshaw Global Investment Conference will be webcast live and available for replay in the Investor Relations section of the Company’s website at sensushealthcare.com.
About Sensus Healthcare
Sensus Healthcare, Inc. is a medical device company that is committed to providing non-invasive and cost-effective treatment for non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy X-ray technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development. Sensus has successfully incorporated SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. For more information, visit http://17s.9e1.myftpupload.com.
LHA Investor Relations
Kim Sutton Golodetz